tiprankstipranks
Trending News
More News >
Salarius Pharmaceuticals Inc (SLRX)
NASDAQ:SLRX

Salarius Pharmaceuticals (SLRX) Stock Statistics & Valuation Metrics

Compare
522 Followers

Total Valuation

Salarius Pharmaceuticals has a market cap or net worth of $1.54M. The enterprise value is $80.56K.
Market Cap$1.54M
Enterprise Value$80.56K

Share Statistics

Salarius Pharmaceuticals has 2,127,286 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding2,127,286
Owned by Insiders2.84%
Owned by Institutions0.72%

Financial Efficiency

Salarius Pharmaceuticals’s return on equity (ROE) is -3.69 and return on invested capital (ROIC) is -330.78%.
Return on Equity (ROE)-3.69
Return on Assets (ROA)-1.84
Return on Invested Capital (ROIC)-330.78%
Return on Capital Employed (ROCE)-3.79
Revenue Per Employee0.00
Profits Per Employee-2.79M
Employee Count2
Asset Turnover0.00
Inventory Turnover0.00

Valuation Ratios

The current PE Ratio of Salarius Pharmaceuticals is -0.32. Salarius Pharmaceuticals’s PEG ratio is >-0.01.
PE Ratio-0.32
PS Ratio0.00
PB Ratio22.34
Price to Fair Value1.17
Price to FCF-0.41
Price to Operating Cash Flow-0.32
PEG Ratio>-0.01

Income Statement

In the last 12 months, Salarius Pharmaceuticals had revenue of 0.00 and earned -5.58M in profits. Earnings per share was -5.79.
Revenue0.00
Gross Profit0.00
Operating Income-5.73M
Pretax Income-5.58M
Net Income-5.58M
EBITDA-5.57M
Earnings Per Share (EPS)-5.79

Cash Flow

In the last 12 months, operating cash flow was -4.35M and capital expenditures 0.00, giving a free cash flow of -4.35M billion.
Operating Cash Flow-4.35M
Free Cash Flow-4.35M
Free Cash Flow per Share-2.05

Dividends & Yields

Salarius Pharmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.88
52-Week Price Change-78.44%
50-Day Moving Average0.75
200-Day Moving Average1.38
Relative Strength Index (RSI)41.57
Average Volume (3m)26.63K

Important Dates

Salarius Pharmaceuticals upcoming earnings date is Aug 6, 2025, TBA Not Confirmed.
Last Earnings DateMay 8, 2025
Next Earnings DateAug 6, 2025
Ex-Dividend Date

Financial Position

Salarius Pharmaceuticals as a current ratio of 1.98, with Debt / Equity ratio of 181.41%
Current Ratio1.98
Quick Ratio1.98
Debt to Market Cap0.13
Net Debt to EBITDA0.40
Interest Coverage Ratio0.00

Taxes

In the past 12 months, Salarius Pharmaceuticals has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00

Enterprise Valuation

Salarius Pharmaceuticals EV to EBITDA ratio is 0.08, with an EV/FCF ratio of 0.10.
EV to Sales0.00
EV to EBITDA0.08
EV to Free Cash Flow0.10
EV to Operating Cash Flow0.10

Balance Sheet

Salarius Pharmaceuticals has $1.80M in cash and marketable securities with $112.23K in debt, giving a net cash position of -$1.69M billion.
Cash & Marketable Securities$1.80M
Total Debt$112.23K
Net Cash-$1.69M
Net Cash Per Share-$0.79
Tangible Book Value Per Share$1.57

Margins

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%

Analyst Forecast

The average price target for Salarius Pharmaceuticals is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast
EPS Growth Forecast79.57%

Scores

Smart ScoreN/A
AI Score29.9
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis